These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1637564)

  • 1. Effects of calcipotriol (MC 903) and calcitriol after topical application on the skin of hairless rats. Much lower effect of calcipotriol on systemic calcium homeostasis.
    Bräutigam M; Hübner H; Rach P; Thieroff-Ekerdt R
    Skin Pharmacol; 1992; 5(2):87-92. PubMed ID: 1637564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris.
    Bourke JF; Iqbal SJ; Hutchinson PE
    Acta Derm Venereol; 1997 May; 77(3):228-30. PubMed ID: 9188878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF; Mumford R; Whittaker P; Iqbal SJ; Le Van LW; Trevellyan A; Hutchinson PE
    J Am Acad Dermatol; 1997 Dec; 37(6):929-34. PubMed ID: 9418759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose topical calcipotriol consistently reduces serum parathyroid hormone levels.
    Bourke JF; Berth-Jones J; Mumford R; Iqbal SJ; Hutchinson PE
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):295-7. PubMed ID: 7955435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single topical application of calcipotriol (50 micrograms/g) ointment has no acute effect on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF; Berth-Jones J; Elouzi H; Wong M; Iqbal SJ; Hutchinson PE
    Clin Exp Dermatol; 1996 Jul; 21(4):320-1. PubMed ID: 8959913
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicokinetics of topically applied calcitriol and calcipotriol in rats.
    Lammers R; van Harten J
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):64-7. PubMed ID: 9627695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral calcium tolerance test in extensive psoriasis treated with topical calcipotriol.
    Gumowski-Sunek D; Rizzoli R; Saurat JH
    Dermatology; 1995; 190(1):43-7. PubMed ID: 7894096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcipotriol: a new drug for topical psoriasis treatment.
    Kragballe K
    Pharmacol Toxicol; 1995 Oct; 77(4):241-6. PubMed ID: 8577633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.
    Ghoreishi M; Bach P; Obst J; Komba M; Fleet JC; Dutz JP
    J Immunol; 2009 May; 182(10):6071-8. PubMed ID: 19414758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriol. A new topical antipsoriatic.
    Kragballe K; Iversen L
    Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.
    Lerche CM; Philipsen PA; Poulsen T; Wulf HC
    Exp Dermatol; 2010 Nov; 19(11):973-9. PubMed ID: 20113348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris.
    Bourke JF; Berth-Jones J; Iqbal SJ; Hutchinson PE
    Br J Dermatol; 1993 Jul; 129(1):74-6. PubMed ID: 8369213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical calcipotriol on calcium metabolism in psoriatic patients: comparison with oral calcitriol.
    Gumowski-Sunek D; Rizzoli R; Saurat JH
    Dermatologica; 1991; 183(4):275-9. PubMed ID: 1809590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF; Iqbal SJ; Hutchinson PE
    Clin Exp Dermatol; 1997 Nov; 22(6):259-61. PubMed ID: 9604449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
    Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine calcium excretion during treatment of psoriasis with topical calcipotriol.
    Berth-Jones J; Bourke JF; Iqbal SJ; Hutchinson PE
    Br J Dermatol; 1993 Oct; 129(4):411-4. PubMed ID: 8217755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of psoriasis with calcipotriol and other vitamin D analogues.
    Kragballe K
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1001-8. PubMed ID: 1479078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo.
    Binderup L
    Pharmacol Toxicol; 1993; 72(4-5):240-4. PubMed ID: 8396769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.